PharmaTher Holdings Ltd. (CSE:PHRM)
0.0400
-0.0050 (-11.11%)
Nov 20, 2026, 12:29 PM EST
PharmaTher Holdings Balance Sheet
Financials in millions CAD. Fiscal year is June - May.
Millions CAD. Fiscal year is Jun - May.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Cash & Equivalents | 0.6 | 0.69 | 0.92 | 2.13 | 5.92 | 9.15 |
Short-Term Investments | 0.17 | 0.23 | 0.2 | 0.17 | 0.33 | 2.97 |
Cash & Short-Term Investments | 0.77 | 0.92 | 1.12 | 2.3 | 6.25 | 12.12 |
Cash Growth | -25.89% | -17.95% | -51.16% | -63.22% | -48.41% | 106.22% |
Other Receivables | 0.02 | 0.01 | 0.02 | 0.02 | 0.06 | 0.03 |
Receivables | 0.02 | 0.01 | 0.02 | 0.02 | 0.06 | 0.03 |
Prepaid Expenses | - | - | - | 0.02 | - | 0.01 |
Total Current Assets | 0.79 | 0.93 | 1.14 | 2.34 | 6.31 | 12.16 |
Property, Plant & Equipment | - | - | - | - | 0 | 0 |
Long-Term Investments | 0.19 | 0.19 | 0.2 | 0.25 | - | - |
Total Assets | 0.98 | 1.12 | 1.34 | 2.59 | 6.31 | 12.16 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Accounts Payable | 0.57 | 0.5 | 0.36 | 0.24 | 0.88 | 0.32 |
Accrued Expenses | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Total Current Liabilities | 0.59 | 0.51 | 0.37 | 0.25 | 0.89 | 0.33 |
Total Liabilities | 0.59 | 0.51 | 0.37 | 0.25 | 0.89 | 0.33 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Common Stock | 8.95 | 8.95 | 8.5 | 8.5 | 8.44 | 8.44 |
Additional Paid-In Capital | 0.27 | 0.27 | 0.71 | 0.55 | 0.65 | 0.65 |
Retained Earnings | -12.95 | -12.72 | -12.35 | -10.83 | -7.78 | -1.37 |
Comprehensive Income & Other | 4.11 | 4.11 | 4.11 | 4.11 | 4.11 | 4.11 |
Shareholders' Equity | 0.39 | 0.61 | 0.97 | 2.34 | 5.42 | 11.83 |
Total Liabilities & Equity | 0.98 | 1.12 | 1.34 | 2.59 | 6.31 | 12.16 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Net Cash (Debt) | 0.77 | 0.92 | 1.12 | 2.3 | 6.25 | 12.12 |
Net Cash Growth | -25.89% | -17.95% | -51.16% | -63.22% | -48.41% | 106.22% |
Net Cash Per Share | 0.01 | 0.01 | 0.01 | 0.03 | 0.07 | 0.15 |
Filing Date Shares Outstanding | 91.02 | 91.02 | 91.02 | 88.52 | 88.17 | 88.17 |
Total Common Shares Outstanding | 91.02 | 91.02 | 91.02 | 88.52 | 88.17 | 88.17 |
Working Capital | 0.2 | 0.42 | 0.77 | 2.09 | 5.42 | 11.83 |
Book Value Per Share | 0.00 | 0.01 | 0.01 | 0.03 | 0.06 | 0.13 |
Tangible Book Value | 0.39 | 0.61 | 0.97 | 2.34 | 5.42 | 11.83 |
Tangible Book Value Per Share | 0.00 | 0.01 | 0.01 | 0.03 | 0.06 | 0.13 |